16209-54-4

Upstream product

• 67-56-1 methanol 
• 1835-11-6 4-benzyloxy-3-methoxyacetophenone 
• 100-44-7 benzyl chloride 
• 110879-31-7 methyl 4-carbethoxy-3-methoxyphenylethanoate 
• 186581-53-3 diazomethane 
• 29973-91-9 4-benzyloxy-3-methoxyphenylacetic acid 
• 110879-32-8 4-carbethoxy-3-methoxyphenylethanoic acid 
• 5487-33-2 O-benzylhomoisovanillic acid 

Downstream Products

• 29973-91-9 4-benzyloxy-3-methoxyphenylacetic acid 
• 110879-30-6 diethyl 4-benzyloxy-3-methoxyphenylmalonate 
• 64881-05-6 1-<4-(benzyloxy)-3-methoxyphenyl>ethan-2-ol 
• 15964-80-4 2-(4-hydroxy-3-methoxyphenyl)acetic acid methyl ester 
• 110879-24-8 5-(4-benzyloxy-3-methoxyphenyl)-1,3,5-triethylbarbituric acid 
• 110879-25-9 5-(4-benzyloxy-3-methoxyphenyl)-1,5-diethylbarbituric acid 
• 110879-28-2 5-(4-benzyloxy-3-methoxyphenyl)-5-ethylbarbituric acid 
• 110879-29-3 diethyl 4-benzyloxy-3-methoxyphenylethylmalonate 
• 94460-54-5 3-Methoxy-4-benzyloxy-phenethyliodid 
• 40456-49-3 1-(2,4-dihydroxyphenyl)-2-(4'-hydroxy-3'-methoxyphenyl)ethanone 
• 306-08-1 Homovanillic acid 
• 21913-98-4 4',7-dihydroxy-3'-methoxyisoflavone 

Relevant academic research and scientific papers

2, 6 BISHETEROARYL-4-AMINOPYRIMIDINES AS ADENOSINE RECEPTOR ANTAGONISTS

4-Aminopyrimidine derivatives of formula (I) FORMULA heteroaryl groups, including pharmaceutically acceptable salts thereof, wherein R1 and R2 are adenosine A2A receptor antagonists useful in the treatment of movement disorders such as Parkinson's disease.

Expedient Synthesis of Polyhydroxyisoflavones

A general and direct synthesis of polyhydroxy isoflavones (3-phenyl-4H-1-benzopyran-4-ones) starting from the corresponding unprotected phenols and arylacetic acids is described.The aryl rings may carry additional alkyl, methoxy and/or halogeno groups.Intermediate polyhydroxydeoxybenzoins (1,2-diphenylethanones) can also be isolated in good yields.

Hypolipidemic analogues of ethyl 4 benzyloxybenzoate

A series of compounds related to ethyl 4-benzyloxybenzoate was synthesized and evaluated for potential hypolipidemic activity in rats. Structure-activity relationships are discussed in terms of cholesterol-lowering activity together with effects on body weight gain and liver lipids. A number of the compounds inhibited cholesterol and free fatty acid biosynthesis from [1-14C]acetate in rat liver slices in vitro. Ethyl 4-benzyloxybenzoate, ethyl 4-benzyloxybenzoic acid, ethyl 4-p-bromobenzyloxybenzoate, and ethyl 4-o-methoxybenzyloxyphenyl acetate exhibited the most favorable spectrum of activity.